Regeneron Antibody Treatment May Not Be as Effective Against New Omicron Covid Variant

Regeneron said on Tuesday that its Covid-19 antibody treatment might be less effective against the Omicron variant of the coronavirus, an indication that the popular and widely beneficial monoclonal antibody drugs may need to be updated in case the new variant spreads aggressively.The company said that previous laboratory analyses and computer modeling of certain mutations…